Earnings Call · Q2 FY2025·2025-07-31

Q2 25EPS +2.06%·Rev n/aQ1 25EPS +2.50%·Rev n/aQ4 24EPS +1.89%·Rev n/aQ3 24EPS +2.74%·Rev n/a⚠ consensus missing

AbbVie Inc. ABBV

Elizabeth Shea — Senior Vice President

Robert A. Michael — Chairman and Chief Executive Officer

Jeffrey Ryan Stewart — Executive Vice President, Chief Commercial Officer

Roopal Thakkar — Executive Vice President, Research and Development, Chief Scientific Officer

Scott T. Reents — Chief Financial Officer

−0.2%1d on move date+0.2% vs SPY3d+4.2%5d+3.7%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABBV calls or request research access.

More ABBV calls Browse calls Request research access